Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals

David Henry and colleagues examine compliance with new disclosure requirements of Medicines Australia, the pharmaceutical industry representative body, and argue that they fall short and instead more comprehensive reporting standards are needed.

Detalles Bibliográficos
Autores principales: Robertson, Jane, Moynihan, Ray, Walkom, Emily, Bero, Lisa, Henry, David
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764857/
https://www.ncbi.nlm.nih.gov/pubmed/19885393
http://dx.doi.org/10.1371/journal.pmed.1000128
Descripción
Sumario:David Henry and colleagues examine compliance with new disclosure requirements of Medicines Australia, the pharmaceutical industry representative body, and argue that they fall short and instead more comprehensive reporting standards are needed.

Ejemplares similares